Exploration Capital, LLC - May 29, 2024 Form 4 Insider Report for Fresh Tracks Therapeutics, Inc. (FRTX)

Role
10%+ Owner
Signature
Stephen L. Gustin on behalf of Exploration Capital, LLC
Stock symbol
FRTX
Transactions as of
May 29, 2024
Transactions value $
$9,580
Form type
4
Date filed
5/31/2024, 05:29 PM
Previous filing
May 23, 2024
Next filing
Jun 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FRTX Common Stock Purchase $69.60 +80 +0.01% $0.87 1.32M May 29, 2024 Direct F1, F2
transaction FRTX Common Stock Purchase $9.05K +9.84K +0.74% $0.92 1.33M May 30, 2024 Direct F1, F2
transaction FRTX Common Stock Purchase $459 +516 +0.04% $0.89 1.33M May 31, 2024 Direct F1, F2
holding FRTX Common Stock 47K May 29, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exploration Capital, LLC ("X-Cap") is the investment manager of Exploration Capital Fund, LP (the "Partnership") and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Exploration Capital General Partner, LLC (the "GP") is the general partner of the Partnership and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership.
F2 Stephen L. Gustin is the Managing Partner of X-Cap and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Mr. Gustin disclaims beneficial ownership of the reported securities held by the Partnership except to the extent of his pecuniary interest.
F3 These shares are directly owned by Stephen L. Gustin.